Physician

Kelly L Hayes, MD

According to 2025 Medicare claims, Kelly Hayes, MD (NPI: 1235133281) practices cardiology in the Erie, PA market, with the plurality of this provider's patient population coming from Erie, PA. This provider's primary affiliated billing organization is REGIONAL HEALTH SERVICES INC (NPI: 1174520654; TIN: 251403958) and primary practice location at 16550-0002.

Hayes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,672 traditional Medicare patients, billed 5,060 HCPCS/CPT codes, and received $205,742 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,242 prescription claims across 1,035 beneficiaries totaling $2,165,092 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 28 claims. Open Payments data shows 16 records totaling $10,515. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $412,230 to $2,165,092. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $116,414 to $9,463.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,191	4,758	$271,518
2016	2,204	4,928	$275,525
2017	2,066	4,553	$244,470
2018	1,748	5,276	$259,238
2019	1,700	4,821	$227,828
2020	1,757	4,865	$232,832
2021	1,769	5,380	$253,517
2022	1,631	4,907	$220,396
2023	1,700	4,883	$202,794
2024	1,672	5,060	$205,742

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	598	3,558	$412,230
2016	656	4,167	$531,095
2017	697	4,871	$719,774
2018	700	4,571	$923,623
2019	727	4,634	$1,026,888
2020	783	4,968	$1,244,160
2021	858	5,573	$1,590,502
2022	923	6,135	$1,982,641
2023	965	6,007	$2,130,129
2024	1,035	6,242	$2,165,092

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	57	$115,482
2016	20	47	$95,771
2017	17	47	$96,422
2018	11	28	$59,298
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	333	387	$81
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	220	236	$18
93227	Electrocardiogram (ecg) 2-day continuous with review by health care professional	193	201	$13
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	333	365	$12
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	239	261	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,326	78,724	$1,492,026
Xarelto	Rivaroxaban	395	26,576	$477,063
Entresto	Sacubitril/Valsartan	23	1,704	$36,247
Jardiance	Empagliflozin	23	1,350	$26,710
Dofetilide	Dofetilide	95	5,334	$25,839

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$315	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$10,200	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kelly L. Hayes, MD?

Tedicare shows public-source Medicare data for Kelly L. Hayes, MD (NPI 1235133281), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kelly L. Hayes, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kelly L. Hayes, MD?

Kelly L. Hayes, MD is linked to REGIONAL HEALTH SERVICES INC (billing NPI 1174520654) in the available physician profile data.

Does Kelly L. Hayes, MD have Open Payments data?

Kelly L. Hayes, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.